Amoxicillin-clavulanate potassium: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
No edit summary |
||
Line 1: | Line 1: | ||
{{CMG}} | __NOTOC__ | ||
{{Amoxicillin-clavulanate potassium}} | |||
{{CMG}}; {{AE}} {{MM}} | |||
==Overview== | |||
==Category== | |||
[[beta-lactam antibiotic]]s | |||
==US Brand Names== | |||
TIMENTIN''''''<sup>®</sup> | |||
==FDA Package Insert== | |||
'''[[Amoxicillin-clavulanate potassium description|Description]]''' | |||
'''| [[Amoxicillin-clavulanate potassium clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Amoxicillin-clavulanate potassium microbiology|Microbiology]]''' | |||
'''| [[Amoxicillin-clavulanate potassium indications and usage|Indications and Usage]]''' | |||
'''| [[Amoxicillin-clavulanate potassium contraindications|Contraindications]]''' | |||
'''| [[Amoxicillin-clavulanate potassium warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Amoxicillin-clavulanate potassium adverse reactions|Adverse Reactions]]''' | |||
'''| [[Amoxicillin-clavulanate potassium drug interactions|Drug Interactions]]''' | |||
'''| [[Amoxicillin-clavulanate potassium overdosage|Overdosage]]''' | |||
'''| [[Amoxicillin-clavulanate potassium dosage and administration|Dosage and Administration]]''' | |||
'''| [[Amoxicillin-clavulanate potassium how supplied|How Supplied]]''' | |||
==Mechanism of Action== | |||
== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] |
Revision as of 23:39, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Category
US Brand Names
TIMENTIN'®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Dosage and Administration | How Supplied